Introduction

Actinomyces sp. represents a genus of Gram-positive bacteria that are integral components of the human microbiome, most notably within the oral cavity and the gastrointestinal tract. These organisms are recognized for their complex interactions with the host and their ability to adapt to various ecological niches. Through the lens of metagenomics and shotgun sequencing, scientists are uncovering how the abundance and functional potential of Actinomyces sp. shift in response to health and disease, serving as a key indicator of microbial diversity and ecosystem stability.

Location of Microbe

Oral Ecosystem

In the oral cavity, Actinomyces sp. is widely distributed across several niches, including the saliva, dental plaque, and the tongue coating. It is frequently found on occlusal surfaces and within the subgingival biofilm, where it interacts with other commensal and opportunistic species.

Gut Ecosystem

Within the gastrointestinal tract, Actinomyces sp. is present in the intestinal lumen and is detected in fecal samples, contributing to the overall taxonomic composition of the lower gut microbiome.

Behavior During Dysbiosis

Oral Ecosystem

During oral dysbiosis, specifically in cases of severe early childhood caries (S-ECC) and type 2 diabetes, certain taxa like Actinomyces sp. oral taxon 448/414 show a significant increase in abundance. Conversely, in some cases of periodontal health, specific strains like Actinomyces sp. OT 170 are more prevalent, suggesting that different strains play divergent roles in health versus disease.

Gut Ecosystem

In the gut, shifts in the abundance of Actinomyces sp. are observed in the context of metabolic alterations. Specifically, these bacteria have been identified as potential biomarkers in patients with obesity, where their presence may be associated with systemic metabolic shifts.

Disease Associations

Oral Ecosystem

In the oral cavity, Actinomyces sp. is strongly associated with several conditions. In children with severe early childhood caries (S-ECC), Actinomyces sp. oral taxon 448/414 is significantly enriched, where it is thought to participate in acid-production metabolisms and the formation of dental plaque. Furthermore, it is associated with halitosis in preschool children, where specific strains like Actinomyces sp. HMT_180 act as biomarkers for the onset of the condition. In the context of type 2 diabetes, the migration of glucose and fructose from plasma to saliva is associated with the enrichment of Actinomyces sp. oral taxon 448, contributing to an increase in glycolytic potential. However, certain Actinomyces species, such as Actinomyces sp. OT 170 and cluster I, are more prevalent in individuals with periodontal health, indicating a protective role for some strains. Additionally, Actinomyces sp. has shown an association with hypoxia in the tumor microenvironment of head and neck squamous cell carcinomas (HNSCC), specifically in the oropharynx and larynx/hypopharynx.

Gut Ecosystem

In the gut, Actinomyces sp. has been identified as a promising diagnostic marker for obesity, with significant effect sizes observed in its abundance compared to non-obese individuals. Additionally, specific strains such as Actinomyces_sp_ICM47 have been highlighted as prognostic biomarkers for predicting survival in patients with hepatocellular carcinoma (HCC) undergoing immune checkpoint inhibitor (ICI) treatment. It has also been noted in studies of diffuse large-B cell lymphoma, where Actinomyces sp. S6 Spd3 showed significant differences across various risk groups, reflecting its association with the systemic immune landscape.

Foods Supporting Healthy Balance

Maintaining a balanced gut ecosystem and oral environment requires a focus on reducing the drivers of dysbiosis. Since Actinomyces sp. and other cariogenic bacteria thrive on fermentable carbohydrates, limiting the intake of refined sugars, sucrose, and high-fructose corn syrup is critical. Reducing the frequency of sugar consumption between meals helps prevent the up-regulation of glycolysis and acid-production pathways that lead to dental decay. Instead, focusing on a diet rich in non-fermentable fibers and complex carbohydrates supports a diverse microbial community and maintains gut barrier integrity. Incorporating a variety of whole vegetables, legumes, and nuts provides the necessary substrates for beneficial microbes while avoiding the metabolic spikes that favor opportunistic pathogens. Adequate hydration and the use of fluoride-containing products can further modulate the oral environment to prevent the overgrowth of acid-producing Actinomyces species.

Actionable Insights

General Microbial Management

• Reduce Refined Sugars: Limit the consumption of sucrose and fructose to decrease the glycolytic potential of oral bacteria and prevent caries.
• Promote Diversity: Consume a wide range of prebiotic fibers (whole grains, vegetables) to support a robust and diverse gut microbiome.
• Glycemic Control: For individuals with diabetes, managing blood glucose levels may mitigate the migration of sugars into saliva, reducing the risk of oral dysbiosis.

Oral Hygiene Practices

• Regular Plaque Control: Implement consistent brushing and flossing to prevent the formation of biofilms where Actinomyces sp. can contribute to plaque accumulation.
• Tongue Care: Regular cleaning of the tongue coating may help manage the populations of Actinomyces sp. associated with halitosis.

Gut and Systemic Health

• Weight Management: Since Actinomyces sp. is associated with obesity markers, maintaining a healthy BMI through diet and exercise may help stabilize its abundance in the gut.

Conclusion

The impact of Actinomyces sp. on human health is highly dependent on the specific strain and the ecological niche it occupies. In the oral ecosystem, it can act as a commensal supporting periodontal health or as a participant in the development of dental caries and halitosis through acid production and plaque formation. In the gut, it serves as a potential biomarker for metabolic conditions such as obesity and may influence prognostic outcomes in oncology. Understanding this host-microbe interaction emphasizes that Actinomyces sp. is not inherently harmful but is an opportunistic pathogen under certain conditions of dysbiosis. A holistic approach to health, focusing on glycemic control and dietary balance, is essential for maintaining these microbes in a state of equilibrium across both the oral and gut ecosystems.

Microbe Cross-Ecosystem Relationship

The relationship between the oral and gut ecosystems is characterized by a continuous exchange of microbes and metabolites, known as the oral-gut axis. Actinomyces sp. is present in both niches, and evidence suggests that these two sites capture complementary signals regarding systemic health. For instance, in patients with obesity, significant microbial shifts are observed in both the oral cavity (saliva and plaque) and the gut (stool), with Actinomyces sp. emerging as a promising biomarker in both environments. The directionality of this relationship suggests that the oral cavity may act as a rich source of microbial biomarkers that reflect the same systemic metabolic alterations found in the gut. While the specific strains may vary—with oral taxa focusing on carbohydrate fermentation and gut taxa potentially interacting with systemic immunity—the concurrent shift in Actinomyces sp. abundance across both ecosystems highlights the interconnected nature of the human microbiome in response to metabolic disease.